Development of Hematopoietic Progenitor and Stem Cells
Hematopoietic stem cell (HSC) transplantation is the maximum broadly used stem mobileular remedy withinside the health center to deal with many blood diseases, including leukemia. However, the dilemma at the supply of hematopoietic stem cells, along with bone marrow, peripheral blood and umbilical wire blood, and the dearth of technique for hematopoietic stem cells growth limition hematopoietic stem cellsbased health center software. Research and improvement of recent era for the manufacturing of transplantable Hematopoietic stem cell in vitro or ex vivo are crucial for destiny medical software improvement. These hematopoietic stem cells impartial hematopoietic cells originate from the embryo and persist withinside the grownup hematopoietic system
Hematopoietic improvement withinside the vertebrate embryo takes place in numerous waves, with every sequential wave generating cohorts of cells which might be accelerated in complexity of blood lineage potential. The first embryonic wave or primitive wave offers upward thrust to unipotent blood mobileular types, and it's miles observed with the aid of using a pro-definitive wave that generates multipotent hematopoietic progenitors. Interestingly, the primary self-renewing Hematopoietic stem cell are detected withinside the mouse embryo as a minimum seventy two hr later than the onset of primitive hematopoiesis, and their preliminary formation takes place in particular withinside the aortic endothelium of the Aorta-Gonad-Mesonephros (AGM) region
- Onset of embryonic hematopoiesis
- Hematopoietic differentiation of Human pluripotent stem cells
- Direct reprogramming from non-hematopoietic cells to hematopoietic stem and progenitor cells
- Future prospective of Human pluripotent stem cells hematopoietic differentiation for translational application
- Hematopoiesis is initiated by transient generation of primitive cell
- Multipotent progenitors are generated in the yolk sac during a second wave of blood cell generation
Related Conference of Development of Hematopoietic Progenitor and Stem Cells
Development of Hematopoietic Progenitor and Stem Cells Conference Speakers
Recommended Sessions
- Acute and Chronic Lymphocytic Leukemia
- Bone Marrow Transplantation
- Development of Hematopoietic Progenitor and Stem Cells
- Digital imaging in Hematology
- Disorders of Vascular Bleeding
- Epigenetic Mechanisms: Emerging Therapeutic Targets for Blood Disorders
- Genetics, Genomics, and Epigenetics
- Genome Editing and Cellular Therapy
- Hematologic Malignancy
- Hematology and Covid-19
- Hematology-Oncology
- Hemoglobin and Iron Metabolism
- Hemoglobinopathies
- Hemophilia
- Hemostasis and Thrombosis
- Immunology and Immunotherapies
- Multiple Myeloma and Other Plasma Cell Disorders
- Myelodysplastic and Myeloproliferative Disorders
- Pediatric Hematology
- Pharmacology of Chemotherapy
- Radiation Oncology or Cancer Therapy
- Transfusion Medicine
- Types of Blood Disorders
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (Italy)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (Italy)
- Blood Disorders and the Immune System - Blood Disorders 2025 (Italy)
- Blood Disorders Diagnosis & Treatment - HEMATOLOGY 2025 (Spain)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (Italy)
- Blood Transfusion - HEMATOLOGY 2025 (Spain)
- Case reports of Hematology - HEMATOLOGY 2025 (Spain)
- CellTherapy - HEMATOLOGY 2025 (Spain)
- COVID-19 and Hematology - HEMATOLOGY 2025 (Spain)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (Italy)
- Disorders of Vascular Bleeding - HEMATOLOGY 2025 (Spain)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (Italy)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (Italy)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (Italy)
- Hematology - HEMATOLOGY 2025 (Spain)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (Italy)
- Hematology Oncology - HEMATOLOGY 2025 (Spain)
- Immunohematology - HEMATOLOGY 2025 (Spain)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (Italy)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (Italy)
- Leukaemia and Lymphoma - HEMATOLOGY 2025 (Spain)
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation - HEMATOLOGY 2025 (Spain)
- New Drug Development in Hematology - HEMATOLOGY 2025 (Spain)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (Italy)
- Patient Blood Management - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (Italy)
- Stem Cell Research - HEMATOLOGY 2025 (Spain)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (Italy)
- Thalassemia - HEMATOLOGY 2025 (Spain)
- Therapeutic Apheresis - HEMATOLOGY 2025 (Spain)
- Thrombosis and Coagulation - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (Italy)
- Transfusion Transmissible Infections - HEMATOLOGY 2025 (Spain)